Track topics on Twitter Track topics that are important to you
Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors.
Although much remains unknown about many mutations and test results rarely clarify the need for any particular response, panel testing has already demonstrated its cost value, which continues to increase every day.
A pair of trials that used checkpoint inhibitors as monotherapy reported lackluster overall response rates in breast cancer.
The post Starting with Mother Nature’s designs will speed up critical development of new antibiotics appeared first on SynBioBeta.
ArticleAn off-label drug prescribed to treat osteoarthritis of the hand when conventional medication has failed is ineffective, according to new research.
Shares of G1 Therapeutics Inc. (GTHX) have returned an impressive 103% year-to-date while the iShares NASDAQ Biotechnology Index (ETF)(IBB) is up a paltry 2.8% during the same period.
Adam Brufsky, MD, PhD, comments the FDA approval of MYL-1401O and discusses the adoption of biosimilars in oncology.
NewsMylan's injectables portfolio is one of the largest and most diversified in the industry, with approximately 80 injectable products in the U.S. across several therapeutic areas, and it's getting bigger.
An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and Social Care Committee, has called for greater clarity regarding the future for medicine access post-Brexit. The committee puts forward that this should be one of the major issues in negotiations, given that the health of the entire UK populations rests on the outcome o...
NICE has announced that it has recommended against the use of Dompe’s recombinant human nerve growth factor eye drop therapy cenegermin on the NHS for the treatment of the rare eye condition neurotrophic keratitis. The UK watchdog cited concerns over its cost-effectiveness in its decision to reject the drug, noting that its £14,500 price tag per eight weeks of treatment would come in above its ...
NewsImperial Logistics leverages the cloud solution to manage the entire distribution process and help ensure the delivery of clean drugs to patients.
NewsThe Eylea (aflibercept) Injection met its 24-week Phase 3 primary endpoint in moderately severe to severe non-proliferative diabetic retinopathy. The company expects U.S. regulatory submission for diabetic retinopathy later this year.
NewsThe company has signed purchase agreements to acquire land in Grand Rapids, Michigan, to add to its growing presence in life sciences, expand its manufacturing capacity, and serve its growing customer base.
Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital of Tokyo, named inventively as “Takeda Global Headquarters”. The completion of the development, which was conducted as part of the “Nihonbashi-honcho 2nd District Project”, was marked by a ceremony attended by Christophe Weber, President and CE...
Technology provides access to new generation of sensitive biosensors to enhance drug discovery. Domain Therapeutics, a France- and Quebec-based biopharmaceutical company that specializes in the research and development of new drug candidates that target transmembrane receptors, announces the signing of a licensing agreement for its bioSens-All™ technology with Bristol-Myers Squibb, a global ...
Researchers at Okayama University report in Oncotarget a promising method for targeting cancer stem cells that cause tumor growth and cancer relapse. The approach involves administering molecules that capture iron, an overload of which is known to be a potential cause of cancer. Cancer stem cells (CSCs) are similar to normal stem cells in that they can differentiate — become cells of a ...
Johnson & Johnson have revealed that its Chief Financial Officer and Executive Vice President, Dominic J. Caruso, will retire from his position in September of this year. Caruso spent close to 12 years in his position as CFO of the pharma giant and was the longest serving in this position during the company’s 132-year history. read more
Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion to gain options on three drug candidates held by Prothena. The deal sees Celgene pay $100 million up front, alongside buying $50 million in shares of Prothena, with milestone payments on the three drugs potentially racking up to a total payment of $2.2 billion. Whether Prothena ...
The post Be your own data scientist — it’s easier than you think appeared first on SynBioBeta.
With years of experience in the pharmaceutical and life sciences sector, Creative Diagnostics launches a large selection of high quality Polymer Particles with multiple sizes from 20 nm to 100 µm. Now its DiagPoly™ spherical polymer particles are available with plain, functional or biomolecules conjugated surfaces. These polymer particles are suitable for a broad of applications i...
Today's Daily Dose brings you news about Antibe's safety study results of ATB-346; Immunovaccine's upcoming clinical trial catalysts; Chiasma's progress in the development of octreotide capsules in the treatment of acromegaly; KemPharm's pharmacokinetic study with a KP415/d-methylphenidate in ADHD and NovaBay's strong financial performance.
The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector.
Stream Bio Ltd, a company that develops and manufactures revolutionary bioimaging products and molecular probes, today presented its revolutionary Conjugated Polymer Nanoparticle (CPN) technology at the opening of the Centre for Process Innovation’s (CPI) National Formulation Centre. The official opening of the centre included tours of the new facilities, networking opportunities for both in...
CASI Pharmaceuticals Inc. (CASI) gained 21.81% on Tuesday, following a $50 million private placement. The financing was led by ETP Global Fund LP, IDG-Accel China Growth Fund III, and Robert W. Duggan, former Chairman and CEO of Pharmacyclics Inc., and is expected to close on or about March 21, 2018.
Telegraph.co.ukGuernsey could become first place in British Isles to have a suicide clinic with vote on assisted dying lawsTelegraph.co.ukGuernsey could become the first place in the British Isles to have a suicide clinic under proposals being put to a vote on the island in May. If pushed through by politicians, it would likely trigger an 18-month consultation period to pull together a ...Voice of...
Cambridge NetworkPure's charity quiz in Ipswich raises over £2000 for mental health charity Suffolk MindCambridge NetworkProfessional recruitment specialists Pure hosted its annual Ipswich charity quiz night last week, bringing local businesses and clients together for a battle of the brains which raised over £2,000 for mental health charity Suffolk Mind. The fun evening ...and more